Acetylation control of the retinoblastoma tumour-suppressor protein (original) (raw)

References

  1. Weinberg, R. A. The retinoblastoma protein and cell control. Cell 81, 323–330 (1995).
    Article CAS Google Scholar
  2. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245–2262 (1998).
    Article CAS Google Scholar
  3. Sherr, C. J. Cancer cell cycles. Science 274, 1672–1677 (1996).
    Article CAS Google Scholar
  4. Shikama, N., Lyon, J. & La Thangue, N. B. The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 7, 230–236 (1997).
    Article CAS Google Scholar
  5. Goodman, R. H. & Smolik, S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14, 1553–1577 (2000).
    CAS PubMed Google Scholar
  6. Hassig, C. A. & Schrieber, S. L. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Opin. 1, 300–308 (1997).
    Article CAS Google Scholar
  7. Brown, C. E., Lechner, T., Howe, L. & Workman, J. L. The many HATs of transcription co-activators. Trends Biol. Sci. 25, 15–18 (2000).
    Article CAS Google Scholar
  8. Gu, W. & Roeder, R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595–606 (1997).
    Article CAS Google Scholar
  9. Sakaguchi, K. et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831–2841 (1998).
    Article CAS Google Scholar
  10. Martinez-Balbás, M. A., Bauer, U.-M., Nielsen, S. J., Brehm, A. & Kouzarides, T. Regulation of E2F-1 activity by acetylation. EMBO J. 19, 662–271 (2000).
    Article Google Scholar
  11. Muraoka, M. et al. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12, 1565–1569 (1996).
    CAS PubMed Google Scholar
  12. Gayther, S. A. et al. Mutations truncating the EP300 acetylase in human cancers. Nature Genet. 24, 300–303 (2000).
    Article CAS Google Scholar
  13. Giles, R. H., Peters, D. J. & Bruening, M. H. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 14, 178–183 (1998).
    Article CAS Google Scholar
  14. Kung, A. L. et al. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14, 272–277 (2000).
    CAS PubMed PubMed Central Google Scholar
  15. Dyson, N. & Harlow, E. Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv. 12, 161–195 (1992).
    CAS PubMed Google Scholar
  16. Stein, R. W., Corrigan, M., Yaciul, P., Whelan, J. & Moran, E. Analysis of E1A-mediated growth regulation functions: binding of the p300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. J. Virol. 64, 4421–4427 (1990).
    CAS PubMed PubMed Central Google Scholar
  17. Wang, H.-G. H., Moran, E. & Yacuik, P. E1A promotes association between p300 and pRB in multimeric complexes required for normal biological activity. J. Virol. 69, 7917–7924 (1995).
    CAS PubMed PubMed Central Google Scholar
  18. Yao, T.-P. et al. Gene dosage-dependent embryonic development and proliferation defects in micelacking the transcriptional integrator p300. Cell 93, 361–372 (1998).
    Article CAS Google Scholar
  19. Ait-Si-Ali, S. et al. CBP/p300 histone acetyltransferase activity is important for the G1/S transition. Oncogene 19, 2430–2437 (2000).
    Article CAS Google Scholar
  20. Ait-Si-Ali, S. et al. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396, 184–186 (1998).
    Article CAS Google Scholar
  21. Bandara, L. R., Adamczewski, J. P., Hunt, T. & La Thangue, N. B. Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352, 249–251 (1991).
    Article CAS Google Scholar
  22. Yang, X.-J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H. & Nakatani, Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319–324 (1996).
    Article CAS Google Scholar
  23. Arany, Z., Newsome, D., Oldread, E., Livingston, D. M. & Eckner, R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374, 81–84 (1995).
    Article CAS Google Scholar
  24. Kraus, V. B., Moran, E. & Nevins, J. R. Promoter-specific _trans_-activation by the adenovirus E1A12S product involves separate E1A domains. Mol. Cell. Biol. 12, 4391–4399 (1992).
    Article CAS Google Scholar
  25. Lassam, N. J., Bayley, S. T. & Graham, F. L. Tumor antigens of human Ad5 in transformed cells and in cells infected with transformation-defective host-range mutants. Cell 18, 781–791 (1979).
    Article CAS Google Scholar
  26. Xiao, Z.-X. et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375,964–698 (1995).
    Article Google Scholar
  27. Adams, P. D. et al. Identification of a cyclin-Cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16, 6623–6633 (1996).
    Article CAS Google Scholar
  28. Zhang, W., Bone, J. R., Edmondson, D. G., Turner, B. M. & Roth, S. Y. Essential and redundant functions of histone acetylation revealed by mutation of target lysines and loss of the Gcn5p acetyltransferase. EMBO J. 17, 3155–3167 (1998).
    Article CAS Google Scholar
  29. Zhang, Q., Yao, H., Vo, N. & Goodman, R. H. Acetylation of adenovirus E1A regulates binding of the transcriptional co-repressor CtBP. Proc. Natl Acad. Sci. USA 97, 14323–14328 (2000).
    Article CAS Google Scholar
  30. Zhang, W. & Bieker, J. J. Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc. Natl Acad. Sci. USA 95, 9855–9860 (1998).
    Article CAS Google Scholar
  31. Boyes, J., Byfield, P., Nakatani, Y. & Ogryzko, V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396, 594–598 (1998).
    Article CAS Google Scholar
  32. Sartorelli, V. et al. Acetylation of MyoD directed by pCAF is necessary for the execution of the muscle program. Mol Cell. 4, 725–734 (1999).
    Article CAS Google Scholar
  33. Keirnan, R. et al. HIV-1 Tat transcriptional activity is regulated by acetylation. EMBO J. 18, 6106–6118 (1999).
    Article Google Scholar
  34. Hseih, J. K. et al. RB regulates the stability and the apoptotic function of p53 via MDM2. Mol. Cell 3, 181–193 (1999).
    Article Google Scholar
  35. Lee, C.-W., Sørensen, T. S., Shikama, N. & La Thangue, N. B. Functional interplay between p53 and E2F through co-activator p300. Oncogene 16, 2695–2610 (1998).
    Article CAS Google Scholar
  36. Shikama, N. et al. A novel co-factor for p300 that regulates the p53 response. Mol. Cell 4, 365–376 (1999).
    Article CAS Google Scholar
  37. Ogryzko, V., Schiltz, R. L., Russanova, V., Howard, B. H. & Nakatani, Y. The transcriptional co-activators p300 and CBP are histone acetyltransferases. Cell 87, 953–959 (1996).
    Article CAS Google Scholar
  38. Morris, L., Allen, K. E. & La Thangue, N. B. Regulation of E2F transcription by cyclinE/Cdk2 kinase mediated through p300/CBP co-activators. Nature Cell Biol. 12, 232–239 (2000).
    Article Google Scholar
  39. Loughran, Ö. & La Thangue, N. B. Apoptotic and growth-promoting activity of E2F modulated by MDM2. Mol. Cell Biol. 20, 2186–2197 (2000).
    Article CAS Google Scholar
  40. Shikama, N. et al. Functional interaction between nucleosome assembly proteins and p300/CREB-binding protein family co-activators. Mol. Cell Biol. 20, 8933–8943 (2000).
    Article CAS Google Scholar
  41. de la Luna, S., Allen, K. E., Mason, S. L. & La Thangue, N. B. Integration of a growth suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor. EMBO J. 18, 212–228 (1999).
    Article CAS Google Scholar

Download references